Characterization of the gene expression profile of neuroblastoma cell line IMR-5 using serial analysis of gene expressionFISCHER, Matthias; BERTHOLD, Frank.Cancer letters. 2003, Vol 190, Num 1, pp 79-87, issn 0304-3835, 9 p.Article

Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastomaSPITZ, Ruediger; HERO, Barbara; ERNESTUS, Karen et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 52-58, issn 1078-0432, 7 p.Article

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastomaSPITZ, Ruediger; HERO, Barbara; ERNESTUS, Karen et al.Medical and pediatric oncology. 2003, Vol 41, Num 1, pp 30-35, issn 0098-1532, 6 p.Article

Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastomaSPITZ, Ruediger; HERO, Barbara; ERNESTUS, Karen et al.Clinical cancer research. 2003, Vol 9, Num 13, pp 4835-4840, issn 1078-0432, 6 p.Article

Asymmetric salivary gland ¹²³I-meta-iodobenzylguanidine uptake in a patient with cervical neuroblastoma and Horner syndromeSIMON, Thorsten; VOTH, Eberhard; BERTHOLD, Frank et al.Medical and pediatric oncology. 2001, Vol 36, Num 4, pp 489-490, issn 0098-1532Article

Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastomaSPITZ, Ruediger; HERO, Barbara; SIMON, Thorsten et al.Clinical cancer research. 2006, Vol 12, Num 11, pp 3368-3373, issn 1078-0432, 6 p., 1Article

The prognostic impact of functional imaging with ¹²³I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol : Results of the German Neuroblastoma Trial NB97SCHMIDT, Matthias; SIMON, Thorsten; HERO, Barbara et al.European journal of cancer (1990). 2008, Vol 44, Num 11, pp 1552-1558, issn 0959-8049, 7 p.Article

Primary dissemination of high-grade gliomas in children : experiences from four studies of the pediatric oncology and hematology society of the german language group (GPOH)BENESCH, Martin; WAGNER, Sabine; BERTHOLD, Frank et al.Journal of neuro-oncology. 2005, Vol 72, Num 2, pp 179-183, issn 0167-594X, 5 p.Article

The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcomeOBERTHUER, André; HERO, Barbara; SPITZ, Rüdiger et al.Clinical cancer research. 2004, Vol 10, Num 13, pp 4307-4313, issn 1078-0432, 7 p.Article

Lacking immunocytological GD2 expression in neuroblastoma : Report of three casesSCHUMACHER-KUCKELKORN, Roswitha; HERO, Barbara; ERNESTUS, Karen et al.Pediatric blood & cancer. 2005, Vol 45, Num 2, pp 195-201, issn 1545-5009, 7 p.Article

Role of Surgery in the Treatment of Patients With Stage 4 Neuroblastoma Age 18 Months or Older at DiagnosisSIMON, Thorsten; HÄBERLE, Beate; HERO, Barbara et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 752-758, issn 0732-183X, 7 p.Article

Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastomaCOCO, Simona; THEISSEN, Jessica; BONASSI, Stefano et al.International journal of cancer (Print). 2012, Vol 131, Num 7, pp 1591-1600, issn 0020-7136, 10 p.Article

Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: A report from the Late Effects Surveillance SystemPAULIDES, Marios; STÖHR, Wolfgang; KOSCIELNIAK, Ewa et al.Vaccine. 2011, Vol 29, Num 8, pp 1565-1568, issn 0264-410X, 4 p.Article

High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary NeuroblastomaSCHULTE, Johannes H; BACHMANN, Hagen S; VANDESOMPELE, Jo et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5082-5092, issn 1078-0432, 11 p.Article

Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trialSIMON, Thorsten; LÄNGLER, Alfred; HARNISCHMACHER, Urs et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 9, pp 653-661, issn 0171-5216, 9 p.Article

Consolidation treatment with chimeric anti-GD2-antibody ch 14.18 in children older than 1 year with metastatic neuroblastomaSIMON, Thorsten; HERO, Barbara; FALDUM, Andreas et al.Journal of clinical oncology. 2004, Vol 22, Num 17, pp 3549-3557, issn 0732-183X, 9 p.Article

Low occurrence of familial neuroblastomas and ganglioneuromas in five consecutive GPOH neuroblastoma treatment studiesCLAVIEZ, Alexander; LAKOMEK, Max; RITTER, Jörg et al.European journal of cancer (1990). 2004, Vol 40, Num 18, pp 2760-2765, issn 0959-8049, 6 p.Article

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in GermanySCHILLING, Freimut H; SPIX, Claudia; BERTHOLD, Frank et al.Cancer letters. 2003, Vol 197, Num 1-2, pp 19-28, issn 0304-3835, 10 p.Article

Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in GermanyBURKHARDT-HAMMER, Tatjana; SPIX, Claudia; BRENNER, Hermann et al.Medical and pediatric oncology. 2002, Vol 39, Num 3, pp 156-162, issn 0098-1532Article

GRHL1 Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC3FABIAN, Johannes; LODRINI, Marco; WIEGAND, Inga et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 9, pp 2604-2616, issn 0008-5472, 13 p.Article

Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group ProjectLONDON, Wendy B; CASTEL, Victoria; MATTHAY, Katherine K et al.Journal of clinical oncology. 2011, Vol 29, Num 24, pp 3286-3292, issn 0732-183X, 7 p.Article

Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt LeukemiaMEINHARDT, Andrea; BURKHARDT, Birgit; KLAPPER, Wolfram et al.Journal of clinical oncology. 2010, Vol 28, Num 19, pp 3115-3121, issn 0732-183X, 7 p.Article

Heterogeneity of the MYCN Oncogene in NeuroblastomaTHEISSEN, Jessica; BOENSCH, Marc; WESTERMANN, Frank et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2085-2090, issn 1078-0432, 6 p.Article

One step generation of fully chimeric antibodies using Cγ1-and Cκ mutant miceJENSEN, Markus; KLEHR, Martin; BERTHOLD, Frank et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 3, pp 338-349, issn 1524-9557, 12 p.Article

Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastomaEICH, Hans Theodor; HERO, Barbara; STAAR, Susanne et al.Strahlentherapie und Onkologie. 2003, Vol 179, Num 4, pp 233-240, issn 0179-7158, 8 p.Article